ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00484341
Recruitment Status : Unknown
Verified October 2015 by MolMed S.p.A..
Recruitment status was:  Active, not recruiting
First Posted : June 8, 2007
Last Update Posted : October 9, 2015
Sponsor:
Information provided by (Responsible Party):
MolMed S.p.A.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2016
  Estimated Study Completion Date : June 2017